Curtis Gale Oltmans, SVP, General Counsel at Fulcrum Therapeutics, Inc. (FULC), bought 1,088 shares at $9.01 ($10K) on 2021-06-28, disclosed to the SEC on 2021-06-29.
Open-market purchase of $10k FULC by SVP, General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |
| ARRY | SELL | 2019-01-29 | $253K | — | Filing → |
| ARRY | SELL | 2019-01-23 | $23K | — | Filing → |
| ARRY | SELL | 2019-01-17 | $712K | — | Filing → |